Adam C. Olson
Experienced in Brain Tumor

Dr. Adam C. Olson

Radiation Oncology
UPMC
UPMC Hillman Cancer Center
300 Halket Street, 
Pittsburgh, PA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients

Experienced in Brain Tumor
UPMC
UPMC Hillman Cancer Center
300 Halket Street, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Adam Olson, MD, is a radiation oncologist in the UPMC Department of Radiation Oncology. He is the medical director of Radiation Oncology at UPMC Children's Hospital of Pittsburgh. At UPMC Shadyside, his clinical practice focuses on the management of genitourinary cancers and soft tissue sarcomas. He is an expert in the use of stereotactic body radiation therapy for prostate cancer and metastatic disease. He is an active clinical researcher and has published extensively on the use of radiation therapy for prostate cancer and pediatric cancers.

Dr. Olson is rated as an Experienced provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Adult Soft Tissue Sarcoma, and Merkel Cell Carcinoma.

His clinical research consists of co-authoring 39 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 4 articles in the study of Brain Tumor.

Specialties
Radiation Oncology
Licenses
Radiology in PA
Board Certifications
American Board Of Radiology
Hospital Affiliations
Magee Womens Hospital Of Upmc Health System
Upmc Presbyterian Shadyside
Upmc Altoona
Upmc Passavant
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

UPMC Hillman Cancer Center
300 Halket Street, Pittsburgh, PA 15213
Call: 412-641-4600
Other Locations
Mary Hillman Jennings Radiation Oncology Center
5230 Centre Avenue, Pittsburgh, PA 15232
Call: 412-623-6720

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


8 Clinical Trials

A Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Advanced Renal Cell Carcinoma With Bone Metastasis (RadiCal)
A Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Advanced Renal Cell Carcinoma With Bone Metastasis (RadiCal)
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Procedure, Drug, Other, Radiation
Study Drug: Cabozantinib S-malate
Study Phase: Phase 2
STEEL: A Randomized Phase II Trial of Salvage Radiotherapy With Standard vs Enhanced Androgen Deprivation Therapy (With Enzalutamide) in Patients With Post-Prostatectomy PSA Recurrences With Aggressive Disease Features
STEEL: A Randomized Phase II Trial of Salvage Radiotherapy With Standard vs Enhanced Androgen Deprivation Therapy (With Enzalutamide) in Patients With Post-Prostatectomy PSA Recurrences With Aggressive Disease Features
Enrollment Status: Active_not_recruiting
Publish Date: December 05, 2025
Intervention Type: Radiation, Drug
Study Drugs: Enzalutamide, Bicalutamide, GnRH analog
Study Phase: Phase 2
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: November 20, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE)
A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE)
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Olaparib, Radium-223
Study Phase: Phase 1/Phase 2
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
Enrollment Status: Active_not_recruiting
Publish Date: November 10, 2025
Intervention Type: Drug, Procedure, Other, Radiation
Study Drugs: Abiraterone acetate, Apalutamide, Bicalutamide, Buserelin, Degarelix, Flutamide, Goserelin, Histrelin, Leuprolide, Prednisone, Triptorelin
Study Phase: Phase 3
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
A Phase II, Double-Blinded, Placebo-Controlled Randomized Trial of Salvage Radiotherapy With or Without Enhanced Anti-Androgen Therapy With Apalutamide in Recurrent Prostate Cancer (BALANCE*)
Enrollment Status: Active_not_recruiting
Publish Date: November 07, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Apalutamide
Study Phase: Phase 2
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2025
Intervention Type: Biological, Drug, Radiation
Study Drugs: Gonadotrophin releasing hormone, Niraparib
Study Phase: Phase 1/Phase 2
Hepatocyte Transplantation for Phenylketonuria
Hepatocyte Transplantation for Phenylketonuria
Enrollment Status: Terminated
Publish Date: August 16, 2023
Intervention Type: Drug, Other, Procedure, Diagnostic test, Radiation, Behavioral
Study Drug: Immunosuppression
Study Phase: Phase 1/Phase 2
View 7 Less Clinical Trials

39 Total Publications

ALARA in Antimicrobial Stewardship: Adapting Radiation Safety Principles to Address Antibiotic Overuse.
ALARA in Antimicrobial Stewardship: Adapting Radiation Safety Principles to Address Antibiotic Overuse.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 26, 2025
View All 39 Publications
Similar Doctors
John C. Flickinger
Distinguished in Brain Tumor
Dr. John C. Flickinger
Radiation Oncology
Distinguished in Brain Tumor
Dr. John C. Flickinger
Radiation Oncology

UPMC Hillman Cancer Center

4401 Penn Avenue, 
Pittsburgh, PA 
 (2.1 miles away)
412-692-9513
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John C. Flickinger, MD, FACR, is a professor of radiation oncology and neurological surgery at the University of Pittsburgh School of Medicine. Dr. Flickinger holds an interest in spine tumors, brain tumors, metastatic diseases, effects of radiation on normal tissue, and the mathematical modeling of radiation response. Dr. Flickinger is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Brain Tumor, Meningioma, Metastatic Brain Tumor, Gamma Knife Radiosurgery, and Rhizotomy.

Advanced in Brain Tumor
Dr. Rodney E. Wegner
Radiation Oncology
Advanced in Brain Tumor
Dr. Rodney E. Wegner
Radiation Oncology

Allegheny Clinic

2600 Haymaker Rd, 
Monroeville, PA 
 (11.0 miles away)
412-856-7740
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Rodney Wegner is a Radiation Oncologist in Monroeville, Pennsylvania. Dr. Wegner is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Small Cell Lung Cancer (SCLC), Metastatic Brain Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Gamma Knife Radiosurgery.

Steven A. Burton
Advanced in Brain Tumor
Dr. Steven A. Burton
Radiation Oncology
Advanced in Brain Tumor
Dr. Steven A. Burton
Radiation Oncology

Mary Hillman Jennings Radiation Oncology Center

5230 Centre Avenue, 
Pittsburgh, PA 
 (1.7 miles away)
412-623-6720
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Steven Burton, MD, is an associate professor of radiation oncology at the University of Pittsburgh School of Medicine. Dr. Burton holds an interest in stereotactic radiosurgery, lymphoma, lung cancer, pancreas cancer, and spinal metastasis. Dr. Burton is rated as a Distinguished provider by MediFind in the treatment of Brain Tumor. His top areas of expertise are Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, Pancreaticoduodenectomy, and Gamma Knife Radiosurgery.

VIEW MORE BRAIN TUMOR DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Olson's expertise for a condition
ConditionClose
    • Distinguished
    • Adult Soft Tissue Sarcoma
      Dr. Olson is
      Distinguished
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Familial Prostate Cancer
      Dr. Olson is
      Distinguished
      . Learn about Familial Prostate Cancer.
      See more Familial Prostate Cancer experts
    • Merkel Cell Carcinoma
      Dr. Olson is
      Distinguished
      . Learn about Merkel Cell Carcinoma.
      See more Merkel Cell Carcinoma experts
    • Prostate Cancer
      Dr. Olson is
      Distinguished
      . Learn about Prostate Cancer.
      See more Prostate Cancer experts
    • Advanced
    • Alveolar Soft Part Sarcoma
      Dr. Olson is
      Advanced
      . Learn about Alveolar Soft Part Sarcoma.
      See more Alveolar Soft Part Sarcoma experts
    • Angiosarcoma
      Dr. Olson is
      Advanced
      . Learn about Angiosarcoma.
      See more Angiosarcoma experts
    • Bone Tumor
      Dr. Olson is
      Advanced
      . Learn about Bone Tumor.
      See more Bone Tumor experts
    • Epithelioid Sarcoma
      Dr. Olson is
      Advanced
      . Learn about Epithelioid Sarcoma.
      See more Epithelioid Sarcoma experts
    • Ewing Sarcoma
      Dr. Olson is
      Advanced
      . Learn about Ewing Sarcoma.
      See more Ewing Sarcoma experts
    • Fibrosarcoma
      Dr. Olson is
      Advanced
      . Learn about Fibrosarcoma.
      See more Fibrosarcoma experts
    View All 13 Advanced Conditions
    • Experienced
    • Anal Cancer
      Dr. Olson is
      Experienced
      . Learn about Anal Cancer.
      See more Anal Cancer experts
    • Angiosarcoma of the Scalp
      Dr. Olson is
      Experienced
      . Learn about Angiosarcoma of the Scalp.
      See more Angiosarcoma of the Scalp experts
    • Brain Tumor
      Dr. Olson is
      Experienced
      . Learn about Brain Tumor.
      See more Brain Tumor experts
    • Chordoma
      Dr. Olson is
      Experienced
      . Learn about Chordoma.
      See more Chordoma experts
    • Familial Pancreatic Cancer
      Dr. Olson is
      Experienced
      . Learn about Familial Pancreatic Cancer.
      See more Familial Pancreatic Cancer experts
    • Ganglioneuroblastoma
      Dr. Olson is
      Experienced
      . Learn about Ganglioneuroblastoma.
      See more Ganglioneuroblastoma experts
    View All 19 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.